SEC Form 4 · accession 0002043317-26-000010
FENNEC PHARMACEUTICALS INC. · FENC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terry L Evans
Officer — Chief Commercial Officer
Period of report
Jul 31, 2026
Accepted (ET)
Aug 3, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001211583
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common SharesF1 | Jul 31, 2026 | A | 168 | $0.00 | A | 21,351 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares released from restriction from shares awarded 3/28/2025.